You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ADMA Sale Disclosure
Grossman Adam S · SEC Form 4 · Filed Nov 5, 2026
Sale
Calculated transaction value
$504K
Grossman Adam S President And CEO
ADMA
ADMA Biologics
ADMA
Transaction date
Nov 5, 2026
Public filing date
Nov 5, 2026
Filing lag
Filed same day
ADMA daily price context
Close on/before transaction
$13.21
Nov 5, 2026
First close after public filing
$12.73
Nov 6, 2026
Return after filing · so far
+3.61%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 42,000 shares @ $12
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001140361-26-042166
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$2.33M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Adma Biologics, Inc. ADMA | Exercise | Nov 5, 2026 | $567K |
| Adma Biologics, Inc. ADMA | Sale | Nov 5, 2026 | $1.26M |
| Adma Biologics, Inc. ADMA | Exercise | Nov 5, 2026 | $0 |
| Adma Biologics, Inc. ADMA Current | Sale | Nov 5, 2026 | $504K |